Improving continence management for people with dementia in the community in Aotearoa, New Zealand: Protocol for a mixed methods study.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
14
02
2023
accepted:
23
06
2023
medline:
21
7
2023
pubmed:
18
7
2023
entrez:
18
7
2023
Statut:
epublish
Résumé
The number of people living with dementia (PLWD) in Aotearoa New Zealand (NZ) was estimated at 96,713 in 2020 and it is anticipated that this number will increase to 167,483 by 2050, including an estimated 12,039 Māori (indigenous people of NZ) with dementia. Experiencing urinary incontinence (UI) or faecal incontinence (FI) is common for PLWD, particularly at the later stages of the disease. However, there is no robust estimate for either prevalence or incidence of UI or FI for PLWD in NZ. Although caregivers rate independent toilet use as the most important activity of daily living to be preserved, continence care for PLWD in the community is currently not systematised and there is no structured care pathway. The evidence to guide continence practice is limited, and more needs to be known about caregiving and promoting continence and managing incontinence for PLWD in the community. This project will seek to understand the extent of the challenge and current practices of health professionals, PLWD, caregivers and family; identify promising strategies; co-develop culturally appropriate guidelines and support materials to improve outcomes; and identify appropriate quality indicators so that good continence care can be measured in future interventions. A four-phase mixed methods study will be delivered over three years: three phases will run concurrently, followed by a fourth transformative sequential phase. Phase 1 will identify the prevalence and incidence of incontinence for PLWD in the community using a cohort study from standardised home care interRAI assessments. Phase 2 will explore continence management for PLWD in the community through a review of clinical policies and guidance from publicly funded continence services, and qualitative focus group interviews with health professionals. Phase 3 will explore experiences, strategies, impact and consequences of promoting continence and managing incontinence for PLWD in the community through secondary data analysis of an existing carers' study, and collecting new cross-sectional and longitudinal qualitative data from Māori and non-Māori PLWD and their caregivers. In Phase 4, two adapted 3-stage Delphi processes will be used to co-produce clinical guidelines and a core outcome set, while a series of workshops will be used to co-produce caregiver resources.
Sections du résumé
BACKGROUND
The number of people living with dementia (PLWD) in Aotearoa New Zealand (NZ) was estimated at 96,713 in 2020 and it is anticipated that this number will increase to 167,483 by 2050, including an estimated 12,039 Māori (indigenous people of NZ) with dementia. Experiencing urinary incontinence (UI) or faecal incontinence (FI) is common for PLWD, particularly at the later stages of the disease. However, there is no robust estimate for either prevalence or incidence of UI or FI for PLWD in NZ. Although caregivers rate independent toilet use as the most important activity of daily living to be preserved, continence care for PLWD in the community is currently not systematised and there is no structured care pathway. The evidence to guide continence practice is limited, and more needs to be known about caregiving and promoting continence and managing incontinence for PLWD in the community. This project will seek to understand the extent of the challenge and current practices of health professionals, PLWD, caregivers and family; identify promising strategies; co-develop culturally appropriate guidelines and support materials to improve outcomes; and identify appropriate quality indicators so that good continence care can be measured in future interventions.
METHODS AND ANALYSIS
A four-phase mixed methods study will be delivered over three years: three phases will run concurrently, followed by a fourth transformative sequential phase. Phase 1 will identify the prevalence and incidence of incontinence for PLWD in the community using a cohort study from standardised home care interRAI assessments. Phase 2 will explore continence management for PLWD in the community through a review of clinical policies and guidance from publicly funded continence services, and qualitative focus group interviews with health professionals. Phase 3 will explore experiences, strategies, impact and consequences of promoting continence and managing incontinence for PLWD in the community through secondary data analysis of an existing carers' study, and collecting new cross-sectional and longitudinal qualitative data from Māori and non-Māori PLWD and their caregivers. In Phase 4, two adapted 3-stage Delphi processes will be used to co-produce clinical guidelines and a core outcome set, while a series of workshops will be used to co-produce caregiver resources.
Identifiants
pubmed: 37463158
doi: 10.1371/journal.pone.0288613
pii: PONE-D-23-04272
pmc: PMC10353819
doi:
Types de publication
Clinical Trial Protocol
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0288613Informations de copyright
Copyright: © 2023 Burholt et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Clin Nurs. 2017 Feb;26(3-4):356-365
pubmed: 27626773
Palliat Med. 2015 Sep;29(8):764-6
pubmed: 25895535
Am J Public Health. 2012 May;102(5):1012-9
pubmed: 22420811
Palliat Med. 2018 Jun;32(6):1124-1132
pubmed: 29667475
Health Psychol Behav Med. 2018 Sep 6;6(1):245-261
pubmed: 34040831
Eur Urol. 2019 Feb;75(2):272-273
pubmed: 30466890
Int J Geriatr Psychiatry. 2018 Jul;33(7):900-906
pubmed: 29468724
Trials. 2012 Aug 06;13:132
pubmed: 22867278
Neurourol Urodyn. 2012 Mar;31(3):390-9
pubmed: 22419382
PLoS Med. 2017 Nov 16;14(11):e1002447
pubmed: 29145404
Neurourol Urodyn. 2013 Apr;32(4):314-24
pubmed: 23129242
Int J Equity Health. 2019 Oct 28;18(1):163
pubmed: 31660988
Int J Geriatr Psychiatry. 2018 Aug;33(8):1098-1104
pubmed: 29766582
Qual Health Res. 2002 Jul;12(6):751-68
pubmed: 12109721
Eur J Ageing. 2019 Sep 20;17(2):251-257
pubmed: 32549876
J Clin Nurs. 2013 Feb;22(3-4):339-46
pubmed: 22788705
Health Policy. 2013 Feb;109(2):187-91
pubmed: 23228520
J Occup Med Toxicol. 2016 Mar 02;11:9
pubmed: 26941829
Australas Emerg Nurs J. 2016 May;19(2):118-26
pubmed: 27173359
Gerontologist. 2008 Dec;48(6):752-71
pubmed: 19139249
Dement Geriatr Cogn Disord. 2015;39(1-2):1-11
pubmed: 25227877
Drugs Aging. 2015 Jul;32(7):559-67
pubmed: 26169438
BMC Health Serv Res. 2014 Sep 20;14:413
pubmed: 25240484
Health Technol Assess. 2001;5(23):iii-157
pubmed: 11785749
BMC Palliat Care. 2017 Sep 4;16(1):46
pubmed: 28870189
Eur J Pers Cent Healthc. 2019;7(3):470-475
pubmed: 34277012
Med Teach. 2017 Jan;39(1):14-19
pubmed: 27841062
PLoS One. 2018 Dec 28;13(12):e0209869
pubmed: 30592741
Clin Transl Gastroenterol. 2018 Oct 25;9(10):200
pubmed: 30356052
J Am Med Dir Assoc. 2020 Nov;21(11):1665-1670
pubmed: 32646821
Nat Rev Dis Primers. 2022 Aug 10;8(1):53
pubmed: 35948559
J Clin Nurs. 2010 Feb;19(3-4):303-12
pubmed: 20500269
Trials. 2018 Apr 24;19(1):247
pubmed: 29690920
Implement Sci. 2016 Mar 17;11:38
pubmed: 26988000
Community Ment Health J. 2014 Oct;50(7):848-53
pubmed: 24449429
Gerontologist. 2017 Feb;57(1):68-81
pubmed: 27852640
Ann Med. 2001 Jul;33(5):337-43
pubmed: 11491192
BMC Geriatr. 2019 Mar 27;19(1):94
pubmed: 30917790
Am J Gastroenterol. 2013 Jan;108(1):113-9
pubmed: 23090350
Trials. 2016 May 04;17(1):230
pubmed: 27142835
Aging Ment Health. 2008 Jan;12(1):14-29
pubmed: 18297476
Trials. 2014 Jun 25;15:247
pubmed: 24962012
Trials. 2019 Jan 6;20(1):12
pubmed: 30612587
J Clin Nurs. 2022 Jul;31(13-14):1933-1946
pubmed: 33091190
Female Pelvic Med Reconstr Surg. 2013 May-Jun;19(3):169-74
pubmed: 23611936
J Wound Ostomy Continence Nurs. 2016 Sep-Oct;43(5):539-44
pubmed: 27607750
BMC Geriatr. 2011 Nov 14;11:75
pubmed: 22081876
Health Promot Int. 2016 Dec;31(4):839-848
pubmed: 26163520
BMJ. 2021 Sep 30;374:n2061
pubmed: 34593508
Aging Ment Health. 2003 Jan;7(1):39-52
pubmed: 12554314
Dementia (London). 2021 Apr;20(3):919-935
pubmed: 32228061
Public Health. 2019 Jul;172:119-124
pubmed: 31171363
J Adv Nurs. 2000 Oct;32(4):1008-15
pubmed: 11095242
N Z Med J. 1994 Sep 28;107(986 Pt 1):374-6
pubmed: 7619104
Age Ageing. 2010 Jan;39(1):31-8
pubmed: 19934075
BMJ Open. 2019 Jul 26;9(7):e026026
pubmed: 31350239
N Z Med J. 2019 Oct 4;132(1503):66-74
pubmed: 31581183
J Clin Epidemiol. 2014 Apr;67(4):401-9
pubmed: 24581294
Int J Equity Health. 2019 Nov 14;18(1):174
pubmed: 31727076
Br J Community Nurs. 2017 Mar 2;22(3):110-114
pubmed: 28252330
Health Soc Care Community. 2015 Jan;23(1):64-78
pubmed: 25135207
PLoS One. 2017 Mar 16;12(3):e0172937
pubmed: 28301485
Aging Clin Exp Res. 2018 Jun;30(6):589-594
pubmed: 28836236
Geriatr Gerontol Int. 2010 Apr;10(2):177-82
pubmed: 20446932
J Wound Ostomy Continence Nurs. 2013 Sep-Oct;40(5):515-23
pubmed: 24448620
Dementia (London). 2019 Jul;18(5):1826-1839
pubmed: 28925299